- Home
- ยป
- Our Products
- »
- Pharmaceutical Injection - 1
Pharmaceutical Injection - 1
Testosterone Undeconate 1000mg/4ml(Cernos Depot)
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 1000mg/4ml |
| Packaging Size | 4 ml |
| Composition | Testosterone (1000 mg) |
| Strength / Dose | 1000 mg |
| Brand Name | Cernos Depot 1000mg |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Treatment | Male hypogonadism |
Overview:
Cernos Depot is an injectable formulation of testosterone undecanoate, a long-acting form of testosterone used primarily in hormone replacement therapy for men with testosterone deficiency.
- Hypogonadism: Treatment of male patients with testosterone deficiency (primary or secondary hypogonadism).
- Hormone Replacement Therapy: Used in men who require testosterone supplementation to restore normal testosterone levels.
Testosterone undecanoate is an ester of testosterone that is slowly released into the bloodstream after injection. It acts by binding to androgen receptors, leading to the development and maintenance of male secondary sexual characteristics, as well as various metabolic effects.
Dosage and Administration:- Typical Dosage: The standard initial dose is often 1000 mg, administered intramuscularly every 10 to 14 weeks, depending on individual response and testosterone levels.
- Administration: Administered via deep intramuscular injection, typically into the gluteal muscle.
- Common: Injection site reactions, headaches, mood changes, acne, and increased body hair.
- Serious: Potential for cardiovascular issues, liver toxicity, or worsening of pre-existing prostate conditions. There may also be a risk of erythrocytosis (increased red blood cell mass).
- Known hypersensitivity to testosterone or any components of the formulation.
- Male patients with prostate cancer or breast cancer.
- Serious liver disease or any history of liver tumors.
- Monitor testosterone levels, hematocrit, and prostate-specific antigen (PSA) levels regularly.
- Use with caution in patients with cardiovascular disease, sleep apnea, or a history of liver disease.
- Store at room temperature, away from light. Follow specific manufacturer guidelines for preparation and storage.
- Inform patients about the purpose of the therapy and expected outcomes.
- Discuss potential side effects and the importance of regular follow-up appointments for monitoring.
- Advise patients to report any unusual symptoms, especially mood changes or signs of cardiovascular problems.
Cernos Depot (testosterone undecanoate 1000 mg/4 ml) is an effective option for treating testosterone deficiency in men. Proper administration and monitoring are crucial for maximizing benefits while minimizing risks. Always consult a healthcare provider for personalized treatment recommendations.
Amino Acids (5% W/V) And Sorbitol (5% W/V) Injection (Nirmin 5-S)
Product Brochure
| Package Size | 500 ml |
| Concentration | 5% |
| Packaging Size | 500 ml |
| Form | Liquid |
| Country of Origin | Made in India |
| Manufacturer | Aculife Healthcare Pvt Ltd |
| Brand Name | Nirmin 5-S |
| Treatment | Nutritional inadequacies |
Overview:
NIRMIN 5-S is a parenteral nutrition solution that combines amino acids and sorbitol, providing essential nutrients for patients unable to meet their nutritional needs through oral intake. Amino acids are vital for protein synthesis, while sorbitol serves as an energy source and helps maintain osmotic balance.
Indications:
- Nutritional Support: For patients who cannot eat or absorb nutrients, including:
- Post-surgical Patients: Nutritional support after surgery or trauma.
- Malnutrition: For those unable to meet nutritional needs due to chronic illnesses.
- Metabolic Disorders: Management of conditions needing specialized nutrition.
- Total Parenteral Nutrition (TPN): As part of comprehensive TPN regimens.
Mechanism of Action:
Amino acids facilitate protein synthesis and tissue repair. Sorbitol provides energy and helps with osmotic regulation, making the solution effective for nutrition.
Dosage and Administration:
- Typical Dosage: Customized based on the patient’s needs. Adults may receive 500 mL to 1000 mL per day, as prescribed.
- Administration: Given intravenously under healthcare supervision, with careful monitoring of infusion rates to avoid complications like fluid overload.
Side Effects:
- Common: Injection site reactions (pain, swelling), nausea, vomiting, and transient hyperglycemia.
- Serious: Rare risk of anaphylaxis, fluid overload, electrolyte imbalances, and hyperammonemia with excessive doses.
Contraindications:
- Hypersensitivity: Allergies to any components of the solution.
- Severe Liver Disease: Risk of ammonia buildup; use with caution.
- Severe Renal Impairment: Caution in patients with kidney dysfunction.
Warnings and Precautions:
- Electrolyte Monitoring: Regular monitoring of electrolytes is crucial due to potential alterations from the solution.
- Fluid Balance: Close monitoring in patients with heart or kidney issues is advised.
- Infection Risk: Aseptic techniques are essential during administration to prevent infections.
Storage:
Store at 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze.
Patient Counseling:
- Explain the injection's purpose in providing nutritional support.
- Discuss potential side effects, including local reactions and allergic symptoms.
- Emphasize adherence to prescribed dosage and infusion rates to minimize risks.
Conclusion:
Amino Acids (5% W/V) and Sorbitol (5% W/V) Injection (NIRMIN 5-S) is vital for parenteral nutrition in patients who cannot consume food orally. Proper administration, monitoring, and patient education are crucial for safe and effective treatment. Always consult a healthcare provider for personalized advice.
Strocit Citicoline 4 ml Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 250mg |
| Dose / Strength | 250 mg/ml |
| Packaging Type | 4 ml |
| Composition | Citicoline 250 mg/ml |
| Brand Name | Strocit 250 mg Injection |
| Manufactured By | Sun Pharmaceutical Industries Ltd |
| Treatment | Disturbances of consciousness resulting from head injuries, brain operation and acute stage of cereb |
Overview:
Strocit is an injectable formulation of citicoline, a neuroprotective agent that plays a crucial role in brain metabolism. It is used to support cognitive function and to promote recovery in conditions associated with neuronal damage, such as stroke, traumatic brain injury, and cognitive decline.
Indications:
- Acute Ischemic Stroke: Used as an adjunctive therapy to improve recovery and support brain function.
- Traumatic Brain Injury: Aids in neurological recovery following head injuries.
- Cognitive Impairment: Support for conditions such as Alzheimer’s disease and other types of dementia.
- Glaucoma: Potentially beneficial in managing retinal health and visual function.
Mechanism of Action:
Citicoline works by enhancing the synthesis of phospholipids in neuronal membranes, particularly phosphatidylcholine. It also promotes the release of neurotransmitters, supports energy metabolism, and has neuroprotective properties that help to stabilize cell membranes and protect against neuronal damage.
Dosage and Administration:
- Typical Dosage: The usual dosage is 2 to 4 ml of citicoline injected intravenously or intramuscularly, depending on the clinical condition and the recommendation of the healthcare provider.
- Administration: Given by a healthcare professional. The injection should be performed under sterile conditions to minimize infection risk.
Side Effects:
- Common: Mild headache, gastrointestinal disturbances (nausea), and transient hypotension.
- Serious: Rare allergic reactions may occur; patients should be monitored for any signs of hypersensitivity.
Contraindications:
- Hypersensitivity: Known allergy to citicoline or any components of the injection.
- Severe Renal Impairment: Use with caution in patients with significant kidney dysfunction.
Warnings and Precautions:
- Monitoring: Patients should be monitored for any adverse reactions during and after administration.
- Caution in Patients with Seizure Disorders: Use with caution in individuals with a history of seizures.
Storage:
Store Strocit Injection at 15°C to 25°C (59°F to 77°F). Protect from light and keep the vial tightly closed. Do not freeze.
Patient Counseling:
- Inform patients about the purpose of the injection, emphasizing its role in supporting brain health and recovery.
- Discuss potential side effects and the importance of reporting any unusual symptoms or allergic reactions.
- Encourage adherence to follow-up appointments for monitoring and evaluation of treatment efficacy.
Conclusion:
Strocit Citicoline 4 ml Injection is a valuable therapeutic option for enhancing cognitive function and supporting recovery in neurological conditions. Proper administration, monitoring, and patient education are essential for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare provider for personalized medical advice.
Prabinex Combipack Injection 5 ml
Minimum Order Quantity: 10 Box
Product Brochure
| Packaging Type | Box |
| Packaging Size | 5 ml |
| Composition | Anhydrous Dextrose 1000mg & Ascorbic Acid 500mg & Nicotinamide 160mg & Pyridoxine 50mg & Riboflavin |
| Brand | Prabinex Combipack Injection |
| Manufacturer | Edoc Life Sciences Pvt Ltd |
| Treatment | Treat or Prevent Vitamin Deficiency |
Overview:
Prabinex Combipack is a parenteral nutritional supplement that combines essential vitamins and minerals designed to address deficiencies and support metabolic processes in patients. It is often used in clinical settings for patients who require enhanced nutritional support, particularly in conditions leading to malabsorption or increased nutritional needs.
Indications:
- Nutritional Support: Used for patients who are unable to meet their nutritional requirements through oral intake.
- Vitamin and Mineral Deficiencies: Effective in treating deficiencies due to malnutrition, chronic diseases, or post-surgical recovery.
- Total Parenteral Nutrition (TPN): Can be utilized as part of a comprehensive TPN regimen in hospitalized patients.
Components:
The Prabinex Combipack typically contains a blend of essential vitamins (such as B vitamins and vitamin C) and minerals (such as zinc and magnesium) that are vital for numerous physiological functions, including energy metabolism and immune support.
Dosage and Administration:
- Typical Dosage: Administered as 5 ml injection, dosed according to the specific needs of the patient and as directed by a healthcare provider.
- Administration: Given intravenously or intramuscularly by a qualified healthcare professional. Proper aseptic techniques should be followed to prevent infection.
Side Effects:
- Common: Local reactions at the injection site (pain, redness), mild gastrointestinal disturbances (nausea, diarrhea).
- Serious: Rare allergic reactions or hypersensitivity; patients should be monitored for any severe reactions.
Contraindications:
- Hypersensitivity: Known allergy to any of the components in the Prabinex formulation.
- Severe Renal Impairment: Use with caution in patients with significant kidney dysfunction, as accumulation of certain components may occur.
Warnings and Precautions:
- Monitoring: Regular monitoring of electrolytes and overall nutritional status is advised during treatment.
- Fluid Balance: Caution in patients with fluid overload or heart conditions.
Storage:
Store Prabinex Combipack Injection at 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze. Ensure the vial is tightly closed when not in use.
Patient Counseling:
- Explain the purpose of the injection in supporting nutritional needs and enhancing recovery.
- Discuss potential side effects and the importance of reporting any unusual symptoms.
- Encourage adherence to prescribed treatment and regular follow-up for monitoring nutritional status.
Conclusion:
Prabinex Combipack Injection 5 ml is an effective option for providing essential nutrients and supporting patients in need of nutritional supplementation. Proper administration, monitoring, and patient education are vital for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare provider for personalized medical advice.
Linezolid Infusion (Linetic 600 mg Infusion)
Product Brochure
| Packaging Size | 300 ML |
| Brand | Linetic 600mg Infusion |
| Composition | Linezolid (600 mg) |
| Packaging Type | 1 Bottle 300 ml Infusion |
| Dose / Strength | 600 mg |
| Manufacturer | Neon Laboratories Ltd |
| Treatment | Severe bacterial infections |
Overview:
Linetic is an intravenous formulation of linezolid, an oxazolidinone antibiotic used primarily to treat serious bacterial infections, especially those caused by Gram-positive bacteria that are resistant to other antibiotics.
- Pneumonia: Effective for both hospital-acquired and community-acquired pneumonia.
- Skin and Soft Tissue Infections: Particularly useful for complicated infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
- Vancomycin-Resistant Enterococci (VRE): Treatment for infections caused by VRE.
Linezolid works by inhibiting bacterial protein synthesis. It binds to the 50S ribosomal subunit, preventing the formation of the initiation complex necessary for protein synthesis.
Dosage and Administration:- Typical Dosage: 600 mg infused intravenously every 12 hours. Dosage may be adjusted based on the type of infection and clinical response.
- Administration: Infusion is typically given over 30 to 120 minutes, administered by a healthcare professional.
- Common: Diarrhea, headache, nausea, vomiting.
- Serious: Risk of serotonin syndrome (especially if taken with other serotonergic agents) and potential for myelosuppression, including thrombocytopenia.
- Hypersensitivity to linezolid or any of its components.
- Caution in patients taking monoamine oxidase inhibitors (MAOIs) or with a history of significant drug interactions.
- Regular monitoring of blood counts is recommended, particularly with prolonged treatment, due to the risk of thrombocytopenia and anemia.
- Use with caution in patients with pre-existing bone marrow suppression.
- Store at room temperature, protected from light. Follow manufacturer guidelines for preparation and storage.
- Inform patients about the purpose of the infusion and its use in treating serious infections.
- Discuss potential side effects, especially the need to report any unusual symptoms, such as mood changes or severe gastrointestinal issues.
Linetic (linezolid 600 mg infusion) is an effective treatment option for serious bacterial infections, particularly those caused by resistant organisms. Careful administration and monitoring are crucial for ensuring patient safety and treatment efficacy. Always consult with a healthcare provider for personalized medical advice.
K Win 0.5ml/1mg Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Pack Size | 0.5 ml |
| Pack Type | Box |
| Strength / Dose | 1 mg |
| Packaging Type | 1 Vial 0.5 ml Injection |
| Composition | Phytomenadione 1mg |
| Brand | K Win 1mg Injection |
| Manufactured By | Mercury Laboratories Ltd |
| Treatment | Hypoprothrombinemia and Vitamin K deficiency |
Overview:
K Win is an injectable formulation containing methyltestosterone, an androgenic steroid used primarily for hormone replacement therapy in men with low testosterone levels and for certain medical conditions related to testosterone deficiency.
- Hypogonadism: Treatment of male patients with low testosterone levels (primary or secondary).
- Certain Conditions: May be used for conditions such as delayed puberty in boys or for women with specific hormone-related disorders, although its use in women is less common.
Methyltestosterone acts as an androgen by binding to androgen receptors, promoting the development and maintenance of male secondary sexual characteristics and influencing various metabolic processes.
Dosage and Administration:- Typical Dosage: The specific dose may vary based on the condition being treated, but it is often administered at a dose of 1 mg intramuscularly, with adjustments made based on individual response and testosterone levels.
- Administration: Administered via deep intramuscular injection by a healthcare professional.
- Common: Acne, fluid retention, mood changes, headache, and changes in libido.
- Serious: Risk of cardiovascular events, liver toxicity, and possible aggravation of existing prostate conditions.
- Known hypersensitivity to methyltestosterone or any components of the formulation.
- Male patients with prostate cancer or breast cancer.
- Severe liver disease or history of liver tumors.
- Monitor testosterone levels and liver function regularly during treatment.
- Use with caution in patients with cardiovascular disease or a history of thromboembolic disorders.
- Patients with pre-existing prostate issues should be closely monitored.
- Store at room temperature, away from light. Follow specific manufacturer guidelines for preparation and storage.
- Inform patients about the purpose of the injection and its expected benefits.
- Discuss potential side effects and emphasize the importance of reporting any unusual symptoms.
- Encourage regular follow-up appointments for monitoring testosterone levels and overall health.
K Win 1 mg injection is an effective option for managing testosterone deficiency in men. Proper administration and monitoring are essential for optimizing treatment outcomes while minimizing risks. Always consult a healthcare provider for personalized treatment recommendations.
Follicle Stimulating Hormone(Gonal F 900 Iu Injection)
Minimum Order Quantity: 10 Piece
Product Brochure
| Strength | 900 IU / 1.5 ml |
| Packaging Size | 1.5 ml |
| Composition | Recombinant follicle stimulating hormone (900 IU) |
| Brand | Gonal F 900 Iu Injection |
| Manufacturer | Merck Ltd |
| Treatment | Female infertility & Male hypogonadism |
Introduction
Gonal-F (containing 900 IU of Follicle Stimulating Hormone or FSH) is a recombinant hormone used in fertility treatments. It stimulates the growth and maturation of ovarian follicles in women and can also support sperm production in men.
Gonal-F is indicated for:
- Infertility Treatments: Often used in women undergoing assisted reproductive technologies (ART) like in vitro fertilization (IVF).
- Hypogonadism in Men: Supports sperm production in men with low testosterone levels.
Gonal-F works by:
- Stimulating Follicle Development: It promotes the growth and maturation of ovarian follicles, increasing the chances of ovulation.
- Enhancing Sperm Production: In men, it stimulates the testes to produce sperm.
- Dosage: The typical dosage varies based on the individual’s treatment plan and response. A healthcare provider will determine the appropriate dosage.
- Administration: Gonal-F is administered via subcutaneous injection. Dosing schedules may differ based on treatment protocols.
Gonal-F is contraindicated in:
- Hypersensitivity: Patients with known allergies to FSH or any components of the formulation.
- Pregnancy: Not recommended for use during pregnancy unless under specific medical advice.
- Ovarian Hyperstimulation Syndrome (OHSS): Risk of OHSS, which can cause severe abdominal pain, swelling, and other complications.
- Multiple Pregnancies: Increased risk of multiple births, which may pose additional health risks.
Common side effects may include:
- Injection site reactions (redness, swelling)
- Headache
- Abdominal pain
- Nausea
Serious adverse effects can include:
- Severe allergic reactions
- Ovarian hyperstimulation syndrome (OHSS)
- Blood clots
Gonal-F may interact with other medications, particularly those affecting fertility. Patients should inform their healthcare provider about all medications, including over-the-counter drugs and supplements.
Storage InstructionsStore Gonal-F (Follitropin alfa) at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light and keep it in the original packaging.
Patient Counseling Information- Advise patients to report any unusual side effects or symptoms of OHSS.
- Discuss the importance of adhering to the prescribed dosage and schedule.
- Educate patients about potential risks, including multiple pregnancies and the importance of regular monitoring during treatment.
Gonal-F 900 IU Injection is an important medication in fertility treatments, promoting follicle development and enhancing reproductive outcomes. Proper management and monitoring are essential for optimizing treatment effectiveness and minimizing risks.
Phytomenadione (K Win 10 mg Injection)
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 10 mg |
| Pack Size | 1 ml |
| Pack Type | Box |
| Drug Composition | Phytomenadione 1 mg |
| Brand Name | K Win 10 mg Injection |
| Manufacturer | Mercury Laboratories Ltd |
| Treatment | Lack of vitamin K |
Phytomenadione, commonly known as Vitamin K1, is an essential fat-soluble vitamin crucial for blood coagulation and bone metabolism. K Win 10 mg Injection is used therapeutically to prevent and treat Vitamin K deficiency, particularly in individuals at risk of bleeding.
IndicationsK Win is indicated for:
- Vitamin K Deficiency: Treatment of deficiency due to malabsorption syndromes, liver disease, or prolonged antibiotic therapy.
- Anticoagulant Reversal: Used to reverse the effects of anticoagulants like warfarin in cases of bleeding or prior to surgical procedures.
- Neonatal Hemorrhagic Disease: Prevention of Vitamin K deficiency bleeding in newborns.
Phytomenadione works by:
- Promoting Coagulation: It aids in the synthesis of clotting factors II (prothrombin), VII, IX, and X in the liver, which are essential for proper blood clotting.
- Dosage: The typical dosage varies based on the indication and patient condition. For adults, the usual dose ranges from 1 to 10 mg, while infants may receive 0.5 to 1 mg as a single dose.
- Administration: K Win is administered via intramuscular or slow intravenous injection, as directed by a healthcare provider.
K Win is contraindicated in:
- Hypersensitivity: Patients with known allergies to phytomenadione or any components of the formulation.
- Severe Liver Disease: In patients with severe hepatic impairment, caution is advised.
- Allergic Reactions: Monitor for potential allergic reactions during administration.
- Anticoagulant Use: Caution in patients receiving anticoagulant therapy; regular monitoring of coagulation parameters is advised.
Common side effects may include:
- Injection site reactions (pain, swelling, or redness)
- Allergic reactions (rare)
- Nausea
- Diarrhea
Serious adverse effects can include:
- Anaphylaxis (in rare cases)
- Thrombosis (due to excessive clotting factor production)
Phytomenadione may interact with other medications, especially anticoagulants. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements.
Storage InstructionsStore K Win (Phytomenadione) at 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze.
Patient Counseling Information- Advise patients to report any unusual symptoms or signs of allergic reactions.
- Discuss the importance of adhering to the prescribed dosage and administration schedule.
- Educate patients about the importance of monitoring their coagulation status, especially if they are on anticoagulant therapy.
K Win 10 mg Injection is an important therapeutic agent for managing Vitamin K deficiency and supporting hemostasis. Proper administration and monitoring are essential to maximize effectiveness and minimize risks.
Pemetrexed (Pemshil 500 mg Injection)
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 500 mg |
| Brand Name | Pemshil 500 mg |
| Manufacturer | Shilpa Medicare Ltd |
| Packaging Size | 1 Vial 1 Injection |
| Composition | Pemetrexed (500 mg) |
| Treatment | Non-small cell lung cancer Malignant pleural mesothelioma |
Pemetrexed, marketed under the brand name Pemshil, is an antineoplastic agent used primarily in the treatment of certain types of cancer, including non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma. It is a folate antimetabolite that disrupts the synthesis of DNA and RNA, inhibiting tumor cell growth.
IndicationsPemshil is indicated for:
- Non-Small Cell Lung Cancer (NSCLC): Used in combination with cisplatin for the treatment of locally advanced or metastatic NSCLC.
- Malignant Pleural Mesothelioma: Indicated for the treatment of patients with malignant pleural mesothelioma, in combination with cisplatin.
Pemetrexed works by:
- Inhibiting Folate-Dependent Enzymes: It inhibits several key enzymes involved in folate metabolism, including thymidylate synthase (TS) and dihydrofolate reductase (DHFR). This inhibition disrupts the synthesis of nucleic acids and leads to cell death.
- Dosage: The typical dosage of Pemshil is 500 mg/m² administered intravenously, typically on the first day of each treatment cycle. The specific regimen may vary based on the patient's condition and treatment plan.
- Administration: Pemshil is given as an intravenous infusion over 10 minutes. Pre-medication with corticosteroids is recommended to reduce the risk of skin rash.
Pemshil is contraindicated in:
- Hypersensitivity: Patients with a known allergy to pemetrexed or any components of the formulation.
- Severe Renal Impairment: Caution is advised in patients with severe renal impairment (creatinine clearance less than 45 mL/min).
- Myelosuppression: Monitor blood counts regularly due to the risk of neutropenia, anemia, and thrombocytopenia.
- Lung Toxicity: Caution is advised in patients with pre-existing lung conditions; pulmonary function should be assessed before treatment.
Common side effects may include:
- Fatigue
- Nausea and vomiting
- Anorexia
- Rash
- Diarrhea
Serious adverse effects can include:
- Severe allergic reactions (anaphylaxis)
- Myelosuppression (including severe neutropenia)
- Renal impairment
Pemetrexed may interact with other medications, particularly those that affect kidney function or hematologic status. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements.
Storage InstructionsStore Pemshil (Pemetrexed) at 2°C to 8°C (36°F to 46°F). Protect from light and keep in the original packaging. Do not freeze.
Patient Counseling Information- Advise patients to report any unusual symptoms, including signs of infection, severe rash, or allergic reactions.
- Discuss the importance of adhering to the prescribed dosage and administration schedule.
- Educate patients about potential side effects and the need for regular monitoring during treatment.
Pemshil 500 mg Injection is a vital medication in the treatment of non-small cell lung cancer and malignant pleural mesothelioma. Proper management and monitoring are essential for optimizing treatment effectiveness and minimizing risks.
Ciclosporin Oral Solution (Arpimune ME Oral Solution 50 ml)
Minimum Order Quantity: 10 Piece
Product Brochure
| Packaging Type | 50 ml in 1 bottle |
| Dose/Strength | 50 ml |
| Composition | Ciclosporin Oral Solution |
| Brand | Arpimune ME Oral Solution 50 ml |
| Manufacturer | RPG Life Sciences Ltd |
| Treatment | Avoidance of organ dismissal in relocate patients |
Ciclosporin is an immunosuppressant medication primarily used to prevent organ transplant rejection and to treat autoimmune diseases. Arpimune ME Oral Solution provides a liquid formulation of ciclosporin, making it easier for patients to ingest and manage their dosage.
IndicationsArpimune ME is indicated for:
- Organ Transplantation: Used as part of a regimen to prevent rejection in kidney, liver, or heart transplants.
- Autoimmune Disorders: Treatment of conditions such as rheumatoid arthritis, psoriasis, and nephrotic syndrome.
Ciclosporin works by:
- Inhibiting T-Lymphocyte Activation: It binds to cyclophilin and inhibits calcineurin, which results in decreased production of interleukin-2 (IL-2) and other cytokines, thus suppressing T-cell activation and proliferation.
- Dosage: The dosage of ciclosporin varies based on the indication and patient-specific factors. Typically, it starts at 3 to 5 mg/kg/day divided into two doses.
- Administration: Arpimune ME Oral Solution is taken orally, preferably on an empty stomach. It should be measured accurately using a syringe or measuring spoon and can be mixed with a small amount of juice for better palatability.
Arpimune ME is contraindicated in:
- Hypersensitivity: Patients with known allergies to ciclosporin or any components of the formulation.
- Uncontrolled Infections: Active infections that have not been adequately treated.
- Nephrotoxicity: Monitor renal function regularly, as ciclosporin can cause nephrotoxicity.
- Infections: Increased risk of infections due to immunosuppression; patients should be monitored for signs of infection.
- Blood Pressure Monitoring: Ciclosporin may cause hypertension; regular monitoring of blood pressure is advised.
Common side effects may include:
- Headache
- Nausea and vomiting
- Diarrhea
- Hypertension
- Tremors
Serious adverse effects can include:
- Nephrotoxicity (renal impairment)
- Severe allergic reactions (anaphylaxis)
- Increased risk of infections (including opportunistic infections)
- Lymphoma and other malignancies (with long-term use)
Ciclosporin may interact with numerous medications, including:
- Antifungals (e.g., ketoconazole)
- Antibiotics (e.g., erythromycin)
- Antiepileptics (e.g., phenytoin) Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs and supplements.
Store Arpimune ME Oral Solution at 15°C to 25°C (59°F to 77°F). Protect from light and keep the bottle tightly closed. Do not freeze.
Patient Counseling Information- Advise patients to report any unusual symptoms or side effects, particularly signs of infection or renal dysfunction.
- Discuss the importance of adhering to the prescribed dosage and administration schedule.
- Educate patients about potential drug interactions and the importance of regular follow-up appointments for monitoring.
Arpimune ME Oral Solution (Ciclosporin) is a crucial immunosuppressant in the management of organ transplant rejection and autoimmune disorders. Proper administration, monitoring, and patient education are essential to optimize therapeutic outcomes and minimize risks.
Vitamin C Ascorbic Acid Injection
Minimum Order Quantity: 10 Box
Product Brochure
| Strength | 250 mg |
| Drug Composition | Vitamin C 150 mg |
| Brand Name | Ascordic Acid Injection |
| Manufacturer | Mankind Pharma Ltd |
| Packaging Type | 1.5 ml in 1 vial |
| Treatment | Vitamin C deficiency |
Overview:
Vitamin C, also known as ascorbic acid, is an essential nutrient and antioxidant used primarily for its therapeutic benefits in treating vitamin C deficiency and enhancing overall immune function. The injectable form provides rapid administration for those who cannot take oral supplements.
Indications:
- Vitamin C Deficiency: Treatment of scurvy and other conditions related to severe deficiency.
- Immune Support: Used to bolster immune response, particularly in critically ill patients or those undergoing surgery.
- Antioxidant Therapy: May help reduce oxidative stress in chronic diseases and support recovery in various health conditions.
- Adjunctive Cancer Therapy: Investigated as an adjunct treatment in some cancer protocols to enhance the effects of chemotherapy.
Mechanism of Action:
Vitamin C acts as a potent antioxidant, protecting cells from oxidative damage. It is involved in collagen synthesis, immune function, and the absorption of iron from plant-based foods. By donating electrons, it neutralizes free radicals and supports various enzymatic reactions in the body.
Dosage and Administration:
- Typical Dosage: Varies based on the indication; for deficiency, typical doses can range from 100 mg to 1,000 mg or more, administered intravenously.
- Administration: Administered by healthcare professionals via slow intravenous injection or infusion. Dosage and rate of infusion depend on patient needs and clinical judgment.
Side Effects:
- Common: Pain or swelling at the injection site, headache, nausea, and gastrointestinal discomfort.
- Serious: Rarely, high doses may lead to kidney stones, increased urination, or hemolysis in individuals with G6PD deficiency.
Contraindications:
- Hypersensitivity: Known allergies to ascorbic acid or any components of the formulation.
- Severe Kidney Disorders: Use with caution in patients with renal impairment due to the risk of kidney stones.
Warnings and Precautions:
- Monitoring: Regular monitoring of renal function is advised, especially in patients receiving high doses.
- Drug Interactions: Caution in patients taking anticoagulants or those with a history of kidney stones.
Storage:
Store at 15°C to 25°C (59°F to 77°F). Protect from light and moisture. Do not freeze.
Patient Counseling:
- Inform patients about the purpose of the injection and the benefits of vitamin C.
- Discuss potential side effects, particularly the importance of reporting any unusual symptoms, especially related to kidney function.
- Emphasize adherence to the prescribed treatment regimen and the necessity for follow-up appointments to monitor health status.
Conclusion:
Vitamin C Ascorbic Acid Injection is an effective therapeutic option for managing vitamin C deficiency and supporting immune health. Proper administration, monitoring, and patient education are essential for optimizing treatment outcomes and minimizing risks. Always consult with a healthcare provider for personalized medical advice.
Ceftriaxone (Monocef 500 mg Injection )
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 500 mg |
| Injection Site | IV & IM |
| Pack Size | 5 ml in 1 vial |
| Brand | Monocef 500 mg Injection |
| Composition | Ceftriaxone 500 mg |
| Manufactured By | Aristo Pharmaceuticals Pvt Ltd |
| Treatment | Bacterial diseases |
Overview:
MONOCEF is an injectable formulation of ceftriaxone, a broad-spectrum cephalosporin antibiotic. It is primarily used to treat various bacterial infections due to its effectiveness against a wide range of Gram-positive and Gram-negative organisms.
Indications:
- Bacterial Infections: Treatment of moderate to severe infections, including:
- Pneumonia: Community-acquired and hospital-acquired pneumonia.
- Meningitis: Effective against bacterial meningitis.
- Skin and Soft Tissue Infections: For complicated skin and soft tissue infections.
- Urinary Tract Infections: Including pyelonephritis.
- Bone and Joint Infections: Such as osteomyelitis.
Mechanism of Action:
Ceftriaxone works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs) on the bacterial cell wall, disrupting cell wall construction, leading to cell lysis and death of the bacteria.
Dosage and Administration:
- Typical Dosage:
- For adults: 1 to 2 g intravenously or intramuscularly every 24 hours, depending on the severity and type of infection.
- For pediatric patients: Dosage varies based on age and weight, typically 50 to 100 mg/kg/day in divided doses.
- Administration: Administered via slow intravenous infusion or intramuscular injection. Ensure proper dilution and administration techniques as recommended.
Side Effects:
- Common: Diarrhea, nausea, vomiting, rash, and pain at the injection site.
- Serious: Risk of anaphylaxis, severe allergic reactions, Clostridium difficile-associated diarrhea, and potential for nephrotoxicity.
Contraindications:
- Hypersensitivity: Known allergy to ceftriaxone or other cephalosporins.
- Neonates: Contraindicated in premature infants and newborns due to the risk of biliary sludging and kernicterus.
Warnings and Precautions:
- Renal Function: Monitor renal function regularly, especially in patients with pre-existing renal impairment.
- Superinfection: Prolonged use may result in superinfection with non-susceptible organisms, including fungi.
Storage:
Store MONOCEF Injection at 2°C to 8°C (36°F to 46°F). Protect from light and moisture. Do not freeze.
Patient Counseling:
- Inform patients about the purpose of the injection and its role in treating bacterial infections.
- Discuss potential side effects and advise them to report any severe reactions, such as rash or difficulty breathing.
- Emphasize the importance of completing the full course of therapy, even if symptoms improve, to prevent resistance.
Conclusion:
Ceftriaxone (MONOCEF 500 mg Injection) is an effective broad-spectrum antibiotic for treating a variety of serious bacterial infections. Proper administration, monitoring, and patient education are crucial for ensuring safety and effectiveness. Always consult with a healthcare provider for personalized medical advice.
Zuventus Cefoperazone Sulbactam (Zostum 1.5) Injection
Minimum Order Quantity: 10 Box
Product Brochure
| Packaging Size | 1.5 gm |
| Dose / Strength | 1.5 gm |
| Pack Size | 1 Injection in 1 vial |
| Composition | Cefoperazone (1000mg) + Sulbactam (500mg) |
| Brand Name | Zostum 1.5 gm Injection |
| Manufacturer | Zuventus Healthcare Ltd |
| Treatment | Bacterial infections |
Overview:
Zostum 1.5 is a combination injectable formulation of cefoperazone and sulbactam, a broad-spectrum antibiotic used to treat a variety of bacterial infections. Cefoperazone is a cephalosporin antibiotic, while sulbactam is a β-lactamase inhibitor that enhances the efficacy of cefoperazone against resistant bacteria.
Indications:
- Bacterial Infections: Effective in treating moderate to severe infections, including:
- Intra-abdominal Infections: Such as peritonitis and abscesses.
- Skin and Soft Tissue Infections: Including those caused by susceptible organisms.
- Respiratory Tract Infections: Such as pneumonia.
- Urinary Tract Infections: Effective for complicated UTIs.
- Bone and Joint Infections: Such as osteomyelitis.
Mechanism of Action:
Cefoperazone works by inhibiting bacterial cell wall synthesis, similar to other β-lactam antibiotics. It binds to penicillin-binding proteins (PBPs), leading to cell lysis and death. Sulbactam protects cefoperazone from degradation by β-lactamase enzymes produced by resistant bacteria, thereby enhancing its antimicrobial activity.
Dosage and Administration:
- Typical Dosage:
- Adults: 1.5 g to 3 g, administered intravenously or intramuscularly every 12 hours, depending on the severity and type of infection.
- Pediatric Patients: Dosage should be determined by the physician based on age, weight, and clinical condition.
- Administration: Administer via slow intravenous infusion or deep intramuscular injection after proper reconstitution and dilution as per the manufacturer’s guidelines.
Side Effects:
- Common: Nausea, vomiting, diarrhea, rash, and pain at the injection site.
- Serious: Risk of allergic reactions, including anaphylaxis; Clostridium difficile-associated diarrhea; potential nephrotoxicity with prolonged use.
Contraindications:
- Hypersensitivity: Known allergy to cefoperazone, sulbactam, or other cephalosporins.
- Severe Hepatic Impairment: Caution is advised in patients with significant liver dysfunction.
Warnings and Precautions:
- Renal Function: Monitor renal function regularly, especially in patients with pre-existing kidney disease or those receiving high doses.
- Superinfection: Long-term use may lead to superinfection with non-susceptible organisms.
Storage:
Store Zostum Injection at 2°C to 8°C (36°F to 46°F). Protect from light and moisture. Do not freeze.
Patient Counseling:
- Inform patients about the purpose of the injection and its role in treating bacterial infections.
- Discuss potential side effects, emphasizing the need to report any severe reactions, such as difficulty breathing or severe gastrointestinal symptoms.
- Advise patients to complete the entire course of therapy, even if symptoms improve, to prevent antibiotic resistance.
Conclusion:
Zuventus Cefoperazone Sulbactam (Zostum 1.5 Injection) is a valuable combination antibiotic for managing various serious bacterial infections, particularly those caused by resistant organisms. Careful administration, monitoring, and patient education are essential to ensure effective treatment and minimize risks. Always consult with a healthcare provider for personalized medical advice.
Piperacillin Tazobactam 4.5 Sodium Sterile (pipzo 4.5 gm Injection )
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 4.5 g |
| Pack Type | Vial |
| Dose/Strength | 4.5 g |
| Composition | Piperacillin (4000 mg) + Tazobactum (500 mg) |
| Brand Name | Pipzo 4.5 gm Injection |
| Manufactured By | Alkem Laboratories Ltd |
| Treatment | Bacterial infections |
Overview:
Pipzo 4.5 gm is a combination injectable formulation of piperacillin, a broad-spectrum penicillin antibiotic, and tazobactam, a β-lactamase inhibitor. This combination enhances the effectiveness of piperacillin against a wide range of Gram-positive and Gram-negative bacteria, making it useful for treating serious infections.
Indications:
- Bacterial Infections: Effective in treating moderate to severe infections, including:
- Intra-abdominal Infections: Such as peritonitis and abscesses.
- Skin and Soft Tissue Infections: Including complicated skin infections.
- Respiratory Tract Infections: Such as pneumonia, especially in hospitalized patients.
- Urinary Tract Infections: Including pyelonephritis.
- Sepsis: Management of septic patients.
Mechanism of Action:
Piperacillin works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It binds to penicillin-binding proteins (PBPs), disrupting normal cell wall formation. Tazobactam inhibits β-lactamase enzymes produced by resistant bacteria, protecting piperacillin from degradation and extending its antibacterial spectrum.
Dosage and Administration:
- Typical Dosage:
- For adults: 4.5 g (piperacillin 4 g and tazobactam 0.5 g) administered intravenously every 6 to 8 hours, depending on the severity and type of infection.
- For pediatric patients: Dosage should be based on weight and clinical condition, typically 100-200 mg/kg/day divided into doses.
- Administration: Administered by slow intravenous infusion or deep intramuscular injection after proper reconstitution and dilution as per the manufacturer's guidelines.
Side Effects:
- Common: Nausea, vomiting, diarrhea, headache, and pain or irritation at the injection site.
- Serious: Risk of allergic reactions, including anaphylaxis; Clostridium difficile-associated diarrhea; liver enzyme elevations; potential nephrotoxicity with prolonged use.
Contraindications:
- Hypersensitivity: Known allergy to piperacillin, tazobactam, or other β-lactam antibiotics.
- Severe Renal Impairment: Use with caution in patients with significant renal dysfunction.
Warnings and Precautions:
- Renal Function: Monitor renal function regularly, especially in patients with pre-existing kidney disease or those receiving high doses.
- Superinfection: Long-term use may lead to superinfection with non-susceptible organisms.
Storage:
Store Pipzo Injection at 2°C to 8°C (36°F to 46°F). Protect from light and moisture. Do not freeze.
Patient Counseling:
- Inform patients about the purpose of the injection and its role in treating bacterial infections.
- Discuss potential side effects, particularly the need to report any severe reactions, such as difficulty breathing, severe gastrointestinal symptoms, or skin rash.
- Emphasize the importance of completing the entire course of therapy, even if symptoms improve, to prevent antibiotic resistance.
Conclusion:
Piperacillin Tazobactam 4.5 gm Injection (Pipzo 4.5 gm) is an effective treatment option for managing various serious bacterial infections, particularly those caused by resistant organisms. Careful administration, monitoring, and patient education are essential for ensuring effective treatment and minimizing risks. Always consult with a healthcare provider for personalized medical advice.
Methylprednisolone Injection (Neo- Drol 40 mg Injection )
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 40mg |
| Packaging Size | 1ml |
| Packaging Type | Vial |
| Composition | Methylprednisolone 40 mg |
| Brand Name | Neo- Drol 40 mg Injection |
| Manufactured By | Neon Laboratories Ltd |
| Treatment | Relief from discomfort |
Overview:
Neo-Drol is an injectable formulation of methylprednisolone, a synthetic corticosteroid used primarily for its anti-inflammatory and immunosuppressive properties. It is commonly used to treat a variety of conditions, including severe allergies, autoimmune disorders, and inflammatory diseases.
Indications:
- Inflammatory Conditions: Treatment of conditions such as rheumatoid arthritis, lupus erythematosus, and severe allergic reactions.
- Autoimmune Disorders: Management of conditions like multiple sclerosis and autoimmune hemolytic anemia.
- Respiratory Conditions: Used in the management of severe asthma and chronic obstructive pulmonary disease (COPD) exacerbations.
- Dermatological Disorders: Effective for severe skin diseases such as eczema and dermatitis.
- Oncology: As part of treatment regimens for certain malignancies and for managing chemotherapy-related symptoms.
Mechanism of Action:
Methylprednisolone works by modulating the immune response and inhibiting the production of inflammatory mediators such as cytokines. It binds to glucocorticoid receptors, influencing gene expression and reducing inflammation and immune reactions.
Dosage and Administration:
- Typical Dosage:
- Initial doses can range from 10 mg to 40 mg or more, depending on the specific condition being treated. The dose may be adjusted based on patient response.
- For acute exacerbations or severe conditions, higher doses may be used initially, followed by tapering.
- Administration: Administered via intramuscular or intravenous injection by a healthcare professional. The route and frequency depend on the clinical condition and patient response.
Side Effects:
- Common: Insomnia, gastrointestinal disturbances (nausea, vomiting), headache, and increased appetite.
- Serious: Risk of infections due to immunosuppression, elevated blood glucose levels, adrenal suppression, and potential for gastrointestinal bleeding with prolonged use.
Contraindications:
- Hypersensitivity: Known allergy to methylprednisolone or any components of the formulation.
- Systemic Fungal Infections: Contraindicated in patients with systemic fungal infections.
Warnings and Precautions:
- Infection Risk: Patients should be monitored for signs of infection due to immunosuppressive effects.
- Adrenal Insufficiency: Prolonged use can suppress adrenal function; consider tapering the dose when discontinuing.
- Gastrointestinal Issues: Use cautiously in patients with a history of peptic ulcer disease or gastrointestinal bleeding.
Storage:
Store Neo-Drol Injection at 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze.
Patient Counseling:
- Inform patients about the purpose of the injection and its role in managing their condition.
- Discuss potential side effects and emphasize the importance of reporting any unusual symptoms, particularly signs of infection or severe gastrointestinal distress.
- Advise patients on the importance of adhering to the prescribed treatment regimen and the need for regular follow-up appointments.
Conclusion:
Methylprednisolone Injection (Neo-Drol 40 mg Injection) is a valuable therapeutic option for managing various inflammatory and autoimmune conditions. Proper administration, monitoring, and patient education are essential for optimizing treatment outcomes and minimizing risks. Always consult with a healthcare provider for personalized medical advice.
Hemorel A Dried Factor VIII 500 Iu Injection
Minimum Order Quantity: 10 Piece
Product Brochure
| Dose / Strength | 500 Iu |
| Packaging Type | 1 Vial in 1 Injection |
| Composition | Coagulation Factor Viii 500iu |
| Brand Name | HemoRel-A Injection |
| Manufacturer | Reliance Formulation Pvt Ltd |
| Uses | Haemophilia A |
Overview: Hemorel A is a medication containing dried factor VIII, which is crucial for blood coagulation. It is primarily used in the treatment and prevention of bleeding episodes in patients with hemophilia A, a genetic disorder caused by a deficiency of factor VIII.
Indications:
- Hemophilia A: Used for the treatment and prevention of bleeding episodes in individuals with factor VIII deficiency.
- Surgical Procedures: Administered to ensure adequate hemostasis during surgical interventions in hemophilia patients.
Components: Hemorel A contains dried factor VIII in a concentration of 500 IU per injection. It is prepared for reconstitution and intravenous administration.
Dosage and Administration:
- Typical Dosage: Dosage varies depending on the severity of factor VIII deficiency, the type of bleeding episode, and individual patient factors. It is usually calculated based on the patient's weight and the desired increase in factor VIII levels.
- Administration: Given intravenously, following reconstitution according to the manufacturer's instructions. Monitoring during administration is essential to assess efficacy and watch for potential adverse reactions.
Side Effects:
- Common: Local reactions at the injection site (pain, redness), mild fever, or allergic reactions.
- Serious: Risk of serious allergic reactions (anaphylaxis) and the development of inhibitors against factor VIII, which can diminish the effectiveness of treatment.
Contraindications:
- Hypersensitivity: Known allergy to factor VIII products or any of the components in the formulation.
- Active Thromboembolic Disease: Use with caution in patients with a history of thromboembolic events.
Warnings and Precautions:
- Monitoring: Regular monitoring of factor VIII levels is advised to ensure effective dosing and to detect any development of inhibitors.
- Infection Risk: Follow proper aseptic techniques during administration to minimize infection risk.
Storage: Store Hemorel A at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the product protected from light and ensure proper handling after reconstitution.
Patient Counseling:
- Explain the purpose of Hemorel A in managing hemophilia A and preventing bleeding episodes.
- Discuss potential side effects and the importance of monitoring for any unusual symptoms or allergic reactions.
- Advise on the importance of adherence to treatment regimens and regular follow-up appointments to assess coagulation status.
Conclusion: Hemorel A (Dried Factor VIII) 500 IU Injection is a vital treatment for individuals with hemophilia A, providing essential support in managing bleeding episodes. Proper administration, monitoring, and patient education are critical for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare provider for personalized medical advice.
Cort-S 100 mg Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 100mg |
| Packaging Size | 2 ml |
| Composition | Hydrocortisone (100mg) |
| Brand Name | Cort-S 100mg injection |
| Manufactured By | Neon Laboratories Ltd |
| Treatment | Allergic Circumstances |
Overview: Cort-S is an injectable formulation of hydrocortisone, a corticosteroid used to provide anti-inflammatory and immunosuppressive effects. It is commonly used in various medical conditions, including adrenal insufficiency, inflammatory diseases, and certain acute allergic reactions.
Indications:
- Adrenal Insufficiency: Management of adrenal crisis in patients with adrenal insufficiency.
- Anti-inflammatory Conditions: Treatment of conditions such as severe allergies, asthma exacerbations, and autoimmune disorders.
- Shock: Used as part of the treatment for septic shock and other forms of shock where adrenal support is necessary.
Components: Cort-S contains hydrocortisone sodium succinate as the active ingredient, typically in a concentration of 100 mg per injection.
Dosage and Administration:
- Typical Dosage: Dosage varies based on the condition being treated. For adrenal crisis, doses can be higher, while maintenance doses may be lower.
- Administration: Administered intravenously or intramuscularly by a healthcare professional, with dosage tailored to the patient’s needs and clinical response.
Side Effects:
- Common: Fluid retention, increased blood sugar levels, mood changes, and gastrointestinal disturbances.
- Serious: Risk of infections, gastrointestinal bleeding, and adrenal suppression with prolonged use.
Contraindications:
- Hypersensitivity: Known allergy to hydrocortisone or any of its components.
- Systemic Fungal Infections: Use is contraindicated in patients with systemic fungal infections.
Warnings and Precautions:
- Monitoring: Patients should be monitored for signs of infection, electrolyte imbalances, and changes in blood glucose levels, particularly with prolonged use.
- Caution in Specific Populations: Use with caution in patients with diabetes, hypertension, or those at risk for infections.
Storage: Store Cort-S at room temperature, away from light and moisture. Do not freeze. Ensure proper handling and disposal of any unused medication.
Patient Counseling:
- Explain the purpose of Cort-S in managing inflammatory conditions and adrenal insufficiency.
- Discuss potential side effects and the importance of reporting any unusual symptoms or reactions.
- Emphasize the need for regular follow-up to monitor the effectiveness of treatment and any adverse effects.
Conclusion: Cort-S (Hydrocortisone Sodium Succinate) 100 mg Injection is an important therapeutic option for managing various inflammatory and adrenal insufficiency conditions. Proper administration, monitoring, and patient education are essential for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare provider for personalized medical advice.
Caritec Carbetocin 100 mcg Injection
Minimum Order Quantity: 10 Bottle
Product Brochure
| Composition | Carbetocin (100 mcg/ml) |
| Packaging Type | 1 Vial in 1 ml Injection |
| Dose / Strength | 100 mg |
| Brand Name | Caritec 100 mcg |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Treatment | Prevention of Postpartum Bleeding |
Overview: Caritec is an injectable formulation of carbetocin, a synthetic analog. It is primarily used to prevent uterine atony and excessive bleeding after cesarean section, particularly in patients at high risk for uterine atony.
Indications:
- Prevention of Uterine Atony: Used to prevent postpartum hemorrhage due to uterine atony following cesarean delivery.
Components: Caritec contains carbetocin as the active ingredient, typically in a concentration of 100 mg per injection.
Dosage and Administration:
- Typical Dosage: The recommended dose is 100 mg administered as a single intravenous injection following the delivery of the baby.
- Administration: Administered slowly by a healthcare professional, usually within 1 minute after delivery, to ensure effective uterine contraction.
Side Effects:
- Common: Nausea, vomiting, headache, and abdominal pain.
- Serious: Risk of water retention, hypertension, and rare allergic reactions.
Contraindications:
- Hypersensitivity: Known allergy to carbetocin or any of its components.
- Severe Cardiovascular Conditions: Should be used cautiously in patients with significant cardiovascular issues.
Warnings and Precautions:
- Monitoring: Blood pressure and fluid balance should be monitored, especially in patients with a history of cardiovascular disease.
- Use in Special Populations: Safety and efficacy in pediatric and elderly populations have not been fully established.
Storage: Store Caritec at 2°C to 8°C (36°F to 46°F). Protect from light and do not freeze. Ensure proper handling and disposal of any unused medication.
Patient Counseling:
- Explain the purpose of Caritec in preventing postpartum hemorrhage and the importance of administration timing.
- Discuss potential side effects and the importance of reporting any severe reactions or unusual symptoms.
- Emphasize adherence to follow-up care for monitoring maternal and neonatal health.
Conclusion: Caritec (Carbetocin) 100 mg Injection is an important option for preventing excessive bleeding after cesarean sections. Proper administration, monitoring, and patient education are critical for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare provider for personalized medical advice.
Amiodon 150 mg Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 150 mg |
| Packaging Size | 3 ml |
| Composition | Amiodarone 150mg |
| Brand Name | Amiodon |
| Manufactured By | Neo Pharma |
| Treatment | Arrhythmias (Irregular Heartbeat) |
Overview: Amiodon is an injectable formulation of amiodarone, an antiarrhythmic medication used to manage and treat various types of cardiac arrhythmias. It is particularly effective for ventricular and supraventricular arrhythmias and is often used in emergency settings.
Indications:
- Ventricular Fibrillation: For the treatment of pulseless ventricular fibrillation and ventricular tachycardia.
- Atrial Fibrillation and Flutter: To restore and maintain normal sinus rhythm in patients with atrial fibrillation or flutter.
- Other Arrhythmias: Used for refractory tachyarrhythmias when other treatments are ineffective.
Components: Amiodon contains amiodarone as the active ingredient, typically in a concentration of 150 mg per injection.
Dosage and Administration:
- Typical Dosage: The initial intravenous dose for ventricular fibrillation or pulseless ventricular tachycardia is usually 300 mg, followed by 150 mg if needed. For other arrhythmias, dosing varies based on the specific condition and clinical setting.
- Administration: Administered intravenously by a healthcare professional, with careful monitoring of cardiac rhythm and vital signs during treatment.
Side Effects:
- Common: Hypotension, bradycardia, nausea, and injection site reactions.
- Serious: Potential for pulmonary toxicity, liver dysfunction, thyroid abnormalities, and significant drug interactions.
Contraindications:
- Hypersensitivity: Known allergy to amiodarone or any of its components.
- Severe Sinus Node Dysfunction: Contraindicated in patients with severe sinus node dysfunction leading to marked bradycardia or other significant heart block.
Warnings and Precautions:
- Monitoring: Continuous cardiac monitoring is essential during administration to detect arrhythmias or changes in heart rate and rhythm.
- Pulmonary Toxicity: Patients should be monitored for respiratory symptoms, as amiodarone can cause pulmonary fibrosis.
- Thyroid Function: Regular monitoring of thyroid function tests is advised, given amiodarone's effects on thyroid hormone levels.
Storage: Store Amiodon at room temperature, away from light and moisture. Do not freeze. Ensure proper handling and disposal of any unused medication.
Patient Counseling:
- Explain the purpose of Amiodon in treating arrhythmias and the importance of monitoring during administration.
- Discuss potential side effects and advise patients to report any unusual symptoms promptly.
- Emphasize adherence to follow-up appointments for ongoing management and monitoring.
Conclusion: Amiodon (Amiodarone) 150 mg Injection is a critical medication for managing serious cardiac arrhythmias. Proper administration, monitoring, and patient education are vital for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare provider for personalized medical advice.
Dixin 0.5 mg Injection
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 0.5mg/2ml |
| Pack Size | 2 ml |
| Pack Type | Box |
| Brand Name | Dixin 0.5 mg |
| Manufacturer | Samarth Lifescience PVT. LTD. |
| Usages | Heart Failure & Arrhythmia |
| Composition | Digoxin 0.5mg |
Overview: Dixin is an injectable formulation of digoxin, a cardiac glycoside used to treat various heart conditions. It enhances cardiac contractility and regulates heart rate, making it beneficial for patients with heart failure and certain types of arrhythmias.
Indications:
- Heart Failure: Used to improve symptoms and exercise tolerance in patients with heart failure.
- Atrial Fibrillation and Atrial Flutter: Helps control heart rate and restore normal rhythm in patients with these arrhythmias.
Components: Dixin contains digoxin as the active ingredient, typically in a concentration of 0.5 mg per injection.
Dosage and Administration:
- Typical Dosage: Initial loading dose may vary; commonly, a total loading dose of 0.5 to 1.0 mg is given, divided into smaller doses over 24 hours. Maintenance doses usually range from 0.125 to 0.5 mg daily, depending on patient response and renal function.
- Administration: Administered intravenously by a healthcare professional. Continuous monitoring of heart rate and rhythm is essential during administration.
Side Effects:
- Common: Nausea, vomiting, dizziness, and diarrhea.
- Serious: Risk of digoxin toxicity, which can present as arrhythmias, visual disturbances, or confusion.
Contraindications:
- Hypersensitivity: Known allergy to digoxin or any components of the formulation.
- Ventricular Fibrillation: Contraindicated in patients with ventricular fibrillation.
Warnings and Precautions:
- Monitoring: Regular monitoring of serum digoxin levels, renal function, and electrolytes (especially potassium) is advised to prevent toxicity.
- Drug Interactions: Be cautious of potential interactions with other medications that may affect digoxin levels or enhance its effects.
Storage: Store Dixin at room temperature, away from light and moisture. Ensure proper handling and disposal of any unused medication.
Patient Counseling:
- Explain the purpose of Dixin in managing heart conditions and the importance of adhering to the prescribed regimen.
- Discuss potential side effects and the need to report any symptoms of toxicity, such as changes in vision or heart rhythm.
- Emphasize the importance of regular follow-up appointments for monitoring and dose adjustments.
Conclusion: Dixin (Digoxin) 0.5 mg Injection is a valuable treatment for heart failure and arrhythmias. Proper administration, monitoring, and patient education are crucial for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare provider for personalized medical advice.
Aggribloc 5 mg Tirofiban Hydrochloride Infusion
Minimum Order Quantity: 10 Vial
Product Brochure
| Strength | 12.5mg/50ml |
| Packaging Size | 1 Vial 100 ml Injection |
| Composition | Tirofiban (5mg) |
| Manufacture By | Abbott |
| Brand | Aggribloc 5mg Infusion |
| Strength / Dose | 5 ml/100 ml |
| Treatment | Avoidance of Heart assault |
Overview: Aggribloc is an intravenous formulation of tirofiban hydrochloride, a glycoprotein IIb/IIIa inhibitor used in the management of acute coronary syndrome (ACS). It helps prevent platelet aggregation, thereby reducing the risk of thrombus formation in patients undergoing percutaneous coronary interventions (PCI).
Indications:
- Acute Coronary Syndrome (ACS): Used for the management of patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI).
- Percutaneous Coronary Intervention (PCI): Administered as an adjunct to improve clinical outcomes during and after PCI procedures.
Components: Aggribloc contains tirofiban hydrochloride in a concentration of 5 mg per infusion.
Dosage and Administration:
- Typical Dosage: The initial bolus is usually 0.4 µg/kg administered intravenously over 30 minutes, followed by a continuous infusion of 0.1 µg/kg/min for up to 24 hours.
- Administration: Given by intravenous infusion, with dosing adjusted based on patient response and clinical guidelines.
Side Effects:
- Common: Bleeding, thrombocytopenia (low platelet count), and hypotension.
- Serious: Risk of major bleeding complications, especially in patients with a history of bleeding disorders or concurrent anticoagulant therapy.
Contraindications:
- Hypersensitivity: Known allergy to tirofiban or any of its components.
- Active Bleeding: Contraindicated in patients with active bleeding or a high risk of bleeding complications.
- Severe Thrombocytopenia: Should not be used in patients with a platelet count less than 150,000/mm³.
Warnings and Precautions:
- Monitoring: Continuous monitoring of platelet counts and signs of bleeding is essential during treatment.
- Caution in Specific Populations: Use with caution in patients with a history of stroke, severe hypertension, or those receiving other anticoagulant therapies.
Storage: Store Aggribloc at room temperature, protected from light. Ensure proper handling and disposal of any unused medication.
Patient Counseling:
- Explain the purpose of Aggribloc in preventing thrombus formation during ACS and PCI.
- Discuss potential side effects, particularly the risk of bleeding, and the importance of reporting any unusual symptoms.
- Emphasize the need for regular follow-up and monitoring during treatment.
Conclusion: Aggribloc (Tirofiban Hydrochloride) 5 mg Infusion is a critical treatment option for managing acute coronary syndromes and supporting patients undergoing percutaneous coronary interventions. Proper administration, monitoring, and patient education are essential for optimizing therapeutic outcomes and minimizing risks. Always consult a healthcare provider for personalized medical advice.